Associated Papers
Effects of Pathogenic Mutants of the Neuroprotective RNase 5-Angiogenin in Amyotrophic Lateral Sclerosis (ALS).
Gotte G
Genes, 2024
NMR Characterization of Angiogenin Variants and tRNAAla Products Impacting Aberrant Protein Oligomerization.
Fagagnini A et al.
International Journal of Molecular Sciences, 2021
Loss of angiogenin function is related to earlier ALS onset and a paradoxical increase in ALS duration.
Aluri KC et al.
Scientific Reports, 2020
Stress Granules and ALS: A Case of Causation or Correlation?
Fernandes N et al.
Advances in Neurobiology, 2018
Prediction of functional loss of human angiogenin mutants associated with ALS by molecular dynamics simulations.
Padhi AK et al.
Scientific Reports, 2013
Structural and molecular insights into the mechanism of action of human angiogenin-ALS variants in neurons.
Thiyagarajan N et al.
Nature Communications, 2012
Targeting angiogenin in therapy of amyotropic lateral sclerosis.
Kishikawa H et al.
Expert Opinion on Therapeutic Targets, 2008
Select a paper to view details